Free Trial
LON:VLG

Venture Life Group (VLG) Share Price, News & Analysis

Venture Life Group logo
GBX 55.50 -0.50 (-0.89%)
As of 07:00 AM Eastern

About Venture Life Group Stock (LON:VLG)

Advanced

Key Stats

Today's Range
55
56.78
50-Day Range
54.10
69.61
52-Week Range
47
72
Volume
65,482 shs
Average Volume
307,245 shs
Market Capitalization
£67.61 million
P/E Ratio
12.70
Dividend Yield
0.09%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Venture Life Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VLG Stock News Headlines

Venture Life Buys Back 200,000 Shares, Updates Voting Rights
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
Venture Life Group reports 32% revenue growth for 2025
Venture Life Buys Back 200,000 Shares for Treasury
See More Headlines

VLG Stock Analysis - Frequently Asked Questions

Venture Life Group's stock was trading at GBX 65.26 at the beginning of 2026. Since then, VLG shares have decreased by 15.0% and is now trading at GBX 55.50.

Venture Life Group plc (LON:VLG) issued its earnings results on Tuesday, March, 31st. The company reported ($1.49) EPS for the quarter. The business had revenue of $35.17 million for the quarter. Venture Life Group had a trailing twelve-month return on equity of 7.82% and a net margin of 17.42%.

Shares of VLG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Venture Life Group investors own include Eagle Point Credit (ECC), Antero Resources (AR), Oxford Lane Capital (OXLC), BATM Advanced Communications (BVC), Kape Technologies (KAPE), Litigation Capital Management (LIT) and Meta Platforms (META).

Company Calendar

Last Earnings
3/31/2026
Today
5/12/2026

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
LON:VLG
CIK
N/A
Fax
N/A
Employees
165
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 4.37
Trailing P/E Ratio
12.70
Forward P/E Ratio
9.04
P/E Growth
5.67
Net Income
£747.21 thousand
Net Margins
17.42%
Pretax Margin
N/A
Return on Equity
7.82%
Return on Assets
1.56%

Debt

Debt-to-Equity Ratio
0.82
Current Ratio
4.71
Quick Ratio
1.48

Sales & Book Value

Annual Sales
£35.17 million
Price / Sales
1.92
Cash Flow
GBX 8.68 per share
Price / Cash Flow
6.40
Book Value
GBX 58.74 per share
Price / Book
0.94

Miscellaneous

Outstanding Shares
121,828,000
Free Float
N/A
Market Cap
£67.61 million
Optionable
Not Optionable
Beta
0.24
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:VLG) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners